Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of Staphylococcus aureus, Belgium, 2013 to 2023.

BackgroundAntimicrobial resistance to mupirocin and fusidic acid, which are used for treatment of skin infections caused by Staphylococcus aureus, is of concern.AimTo investigate resistance to fusidic acid and mupirocin in meticillin-susceptible S. aureus (MSSA) from community-acquired skin and soft tissue infections (SSTIs) in Belgium.MethodsWe collected 2013-2023 data on fusidic acid and mupirocin resistance in SSTI-associated MSSA from two large Belgian laboratories. Resistant MSSA isolates sent to the Belgian Staphylococci Reference Centre were spa-typed and analysed for the presence of th... Mehr ...

Volltext
Verfasser: Yin, Nicolas
Michel, Charlotte
Makki, Nadia
Deplano, Ariane
Milis, Alisha
Prevost, Benoit
Miendje-Deyi, Veronique Yvette
Hallin, Marie
Martiny, Delphine
Dokumenttyp: Artikel
Erscheinungsdatum: 2024
Schlagwörter: Sciences bio-médicales et agricoles / Humans / Mupirocin -- pharmacology / Fusidic Acid -- pharmacology / Anti-Bacterial Agents -- pharmacology / Impetigo -- microbiology -- epidemiology -- drug therapy / Belgium -- epidemiology / Staphylococcus aureus -- drug effects -- genetics -- isolation & purification / Microbial Sensitivity Tests / Staphylococcal Infections -- epidemiology -- microbiology -- drug therapy / Whole Genome Sequencing / Drug Resistance / Bacterial -- genetics / Child / Male / Female / Soft Tissue Infections -- microbiology -- epidemiology / Community-Acquired Infections -- microbiology -- epidemiology -- drug therapy / Adult / Belgium / Exfoliatins / Fusidic Acid / Impetigo / Mupirocin / Staphylococcus aureus / Virulence
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28550318
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/373901